A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.

ABSTRACT:

SUBMITTER: Modi D 

PROVIDER: S-EPMC6743316 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature